Article
PDF file of exhibitors who will be at WOC 2008 in Hong Kong.
Melt Pharmaceuticals doses final patient in phase 3 trial of MELT-300
Innovation Series: AI’s impact on managing ocular surface disease with Peter J. McDonnell, MD, and Laura M. Periman, MD
Nanoscope to submit BLA for MCO-010 to treat retinitis pigmentosa
Innovation Series: What a noninvasive eye drop approach may mean for the future of keratoconus
MJH Life Sciences, parent of Ophthalmology Times, acquires EnVision Summit
Doheny Eye Institute ophthalmologists to present at the AAO 2024 Annual Meeting
